Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • News
    • Hospitals &...

    Hospitals & Diagnostics

    Indian Genetics startup MedGenome raises Rs 415 crore in funding led by LeapFrog Investments

    Indian Genetics startup MedGenome raises Rs 415 crore in funding led by LeapFrog Investments

    Medical Dialogues Bureau3 April 2020 2:17 PM IST
    New Delhi: Genetic diagnostics firm MedGenome has said it has raised USD 55 million (over Rs 415 crore) in funding led by LeapFrog...
    FDA warns about potential cybersecurity vulnerabilities for certain GE Healthcare Clinical Information Central Stations and Telemetry Servers

    FDA warns about potential cybersecurity vulnerabilities for certain GE Healthcare Clinical Information Central Stations and Telemetry Servers

    Medical Dialogues Bureau24 Jan 2020 10:50 AM IST
    US: U.S. Food and Drug Administration is issuing a safety communication informing health care providers, facilities and patients about cybersecurity...
    Metropolis Healthcare signs binding agreement to buy Shraddha Diagnostics

    Metropolis Healthcare signs binding agreement to buy Shraddha Diagnostics

    Medical Dialogues Bureau18 Jan 2020 11:37 AM IST
    New Delhi: Pan-India pathology specialist chain Metropolis Healthcare Ltd. has signed a binding agreement to acquire Ahmedabad-based Shraddha...
    Capacit

    Capacit'e Infraprojects bags Rs 407 crore order in Mumbai

    MD bureau16 Jan 2020 11:04 AM IST
    NEW DELHI: Capacit'e Infraprojects on Wednesday said it has bagged an order worth Rs 407 crore for construction of a hospital building in Mumbai....
    Indira IVF to invest Rs 80 crore to expand presence in south India by 2020

    Indira IVF to invest Rs 80 crore to expand presence in south India by 2020

    Farhat Nasim28 Dec 2019 10:00 AM IST
    "With 81 centres currently spread across the county, we would be coming up with 15-20 new centres in south India. We would be investing around Rs...
    Genomica, HuaSin Science complete first CLART diagnostic equipment for early diagnosis of cancer in China

    Genomica, HuaSin Science complete first CLART diagnostic equipment for early diagnosis of cancer in China

    Medical Dialogues Bureau3 Dec 2019 9:00 AM IST
    New Delhi: GENOMICA, the molecular diagnostics company belonging to the PharmaMar Group begins to materialize its first contract in China with the...
    Cygnus Medicare sells majority stake to Amar Ujala for Rs 130 crore

    Cygnus Medicare sells majority stake to Amar Ujala for Rs 130 crore

    Farhat Nasim25 Nov 2019 12:00 PM IST
    The investment of Rs 130 crore includes a significant primary commitment which includes the merger of two Ujala Healthcare hospitals as well as the...
    Metropolis Healthcare Q2 profit up 44 pc to Rs 43 crore

    Metropolis Healthcare Q2 profit up 44 pc to Rs 43 crore

    Medical Dialogues Bureau16 Nov 2019 9:15 AM IST
    The profit after tax works out to Rs 43 crore in Q2 FY20, up 43.7 per cent from Rs 30 crore in Q2 FY19.Mumbai: Leading diagnostic service provider...
    Fujifilm Max Healthcare to jointly train doctors in breast cancer detection

    Fujifilm Max Healthcare to jointly train doctors in breast cancer detection

    Medical Dialogues Bureau17 Oct 2019 9:28 AM IST
    New Delhi: Max Healthcare super speciality hospital in the National Capital on Tuesday signed a partnership with Japan's Fujifilm to train doctors in...
    Paras Healthcare ties up with J K Hospital, plans Rs 50 crore investment for comprehensive services

    Paras Healthcare ties up with J K Hospital, plans Rs 50 crore investment for comprehensive services

    Medical Dialogues Bureau8 Oct 2019 9:50 AM IST
    "We are planning an investment of around Rs 50 crore for setting up an advanced cancer care unit, an additional cath lab as well as an IVF unit in the...
    Dr Lal PathLabs to acquire 70 percent stake in Amins Pathology Referral Laboratory

    Dr Lal PathLabs to acquire 70 percent stake in Amins Pathology Referral Laboratory

    Medical Dialogues Bureau3 Oct 2019 4:34 PM IST
    New Delhi: Diagnostic chain Dr Lal PathLabs said the board of its arm PathLabs Unifiers has approved acquisition of 70 per cent stake in Amins...
    OncoStem Diagnostics named

    OncoStem Diagnostics named 'Best Innovation- Cancer Risk Assessment' by NASSCOM Life sciences and healthcare innovation forum

    Medical Dialogues Bureau29 Sept 2019 9:57 AM IST
    Bangalore, : OncoStem Diagnostics, an Oncology focused company that enables personalised cancer treatment was named as 'Best Innovation- Cancer Risk...
    Next

    Popular Stories

    Ayurvedic Medicines for Blood Sugar, Diet containing Metformin Hydrochloride: Ayurveda Firm Booked

    Ayurvedic Medicines for Blood Sugar, Diet containing Metformin Hydrochloride: Ayurveda Firm Booked

    Laurus Labs gets 2 USFDA observations for Visakhapatnam facility

    Laurus Labs gets 2 USFDA observations for Visakhapatnam facility

    Aurobindo Pharma gets USFDA nod for Fluoxetine Tablets

    Aurobindo Pharma gets USFDA nod for Fluoxetine Tablets

    Transasia-Erba group unveils TB testing device MX 16

    Transasia-Erba group unveils TB testing device MX 16

    After giving exemption, NPPA asks Meril Life Sciences for MRP of its stent

    After giving exemption, NPPA asks Meril Life Sciences for MRP of its stent

    Rising prices of hydroxychloroquine raw material forces small scale pharmas in Haridwar to stop production

    Rising prices of hydroxychloroquine raw material forces small scale pharmas in Haridwar to stop...

    Union Pharma Secretary Holds video conference with Pharma manufacturers and associations, takes feedback

    Union Pharma Secretary Holds video conference with Pharma manufacturers and associations, takes...

    Philips announces DEFINE GPS global multicenter study to assess outcomes of PCI procedures guided by integrated iFR and interventional X-ray images

    Philips announces DEFINE GPS global multicenter study to assess outcomes of PCI procedures guided by...

    View All

    • Email: info@medicaldialogues.in
    • Phone: 011 - 4372 0751

    Website Last Updated On : 13 Oct 2022 5:14 AM GMT
    Company
    • About Us
    • Contact Us
    • Our Team
    • Reach our Editor
    • Feedback
    • Submit Article
    Ads & Legal
    • Advertise
    • Advertise Policy
    • Terms and Conditions
    • Privacy Policy
    • Editorial Policy
    • Comments Policy
    • Disclamier
    Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

    Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

    © 2025 - Medical Dialogues. All Rights Reserved.
    Powered By: Hocalwire
    X
    We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok